Effects of CETP and APOE polymorphisms on lipoprotein levels in patients with obstructive sleep apnea Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012
The relationship between obstructive sleep apnea syndrome and apolipoprotein E allels Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011
LATE-BREAKING ABSTRACT: Effects of APOE genotype and hypoxia on plasma lipids in obstructive sleep apnoea Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013
Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels Source: Eur Respir J 2006; 27: 121-127 Year: 2006
Serum vitamin D, physical activity and the obstructive sleep apnea syndrome Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012
Relations between cystatin C plasma concentration and cardiovascular complications in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea}, Source: Eur Respir J 2012; 40: 1046-1048 Year: 2012
Serum fibrinogen in patients with obstructive sleep apnea Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Serum leptin levels in obstructive sleep apnoea patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
Plasma total antioxidant status in obstructive sleep apnea men Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Associations between increased serum leptin levels and the severity of obstructive sleep apnoea independent of obesity Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Correlation between severity of obstructive sleep apnea (Osa) and serum total cholesterol: Hdl cholesterol (Tc:Hdl) ratio Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
The impact of obstructive sleep apnea syndrome (SAOS) on serum testosterone level Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
Influence of body weight on plasma NT-proBNP in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Serum resistin level in pediatric obstructive sleep apnea Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases Year: 2008
Effect of arterial hypertension, obesity and overnight desaturation on plasma uric acid concentration in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
The role of vitamin D in obstructive sleep apnoea syndrome Source: Breathe, 14 (3) 206; 10.1183/20734735.000618 Year: 2018